Products Quality Lab Reports Knowledge Calculator FAQ 💬 Get in touch
NAD+ vial
Energy

NAD+.

Available Variants
100 mg 250 mg 500 mg 1000 mg

Research area: Energy

🛡️
For research purposes only. Not intended for use in humans or animals.
Longevity & energy metabolism research

About NAD+

NAD+ is studied in research on cellular energy metabolism and longevity. NAD+ acts as a central cofactor of the mitochondrial electron transport chain and is involved in roughly 90% of cellular ATP production.

Research Application

Studied in longevity and energy-metabolism research as a central cofactor of cellular ATP production. Numerous human studies exist for oral precursors (NMN, NR); the direct injectable form is considerably less studied.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

100 mg, 250 mg, 500 mg, 1000 mg
Lyophilized powder
Energy
see lab reports →
Not a peptide – coenzyme (nicotinamide adenine dinucleotide)
No approved drug status for the injectable form. Numerous human studies exist for oral precursors (NMN, NR); direct injectable use is considerably less studied.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Research on longevity and energy metabolism is primarily supported by preclinical data.

  • Yoshino M, et al. Science. 2021;372(6547):1224–1229. PMID 33888596
  • Martens CR, et al. Nature Communications. 2018;9(1):1286. PMID 29599478

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Question about NAD+?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram
← Back to overview